Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... their study in the Journal of the National Comprehensive Cancer Network (Management of Adrenocortical Carcinoma. Journal of the National Comprehensive Cancer Network, 2009;7(7):752-759). ...
2009 SEP 14 ... "In the recommended staging system for adrenocortical carcinoma, nuclear medicine modalities are optional. In cases of distorted Postoperative anatomy ...
2009 SEP 21 ... that will evaluate the use of OSI-906 for patients with locally advanced or metastatic adrenocortical carcinoma (ACC). The study is designed to determine overall survival for patients receiving ...
2009 NOV 2 ... and young adulthood (ie, breast cancer). R337H has also been detected in children with adrenocortical carcinoma without a documented family history of cancer. The mutation is estimated to occur in ...
2009 NOV 9 ... tumors, were all negative, as well as melanomas, which are similar to high portion of adrenocortical tumors that react with melan-A. However, all paragangliomas, some carcinoids, and ... Kidney, Nephrology, Oncology, Pheochromocytoma, Renal Cell Cancer, Renal Cell Carcinoma, Semmelweis University. This article was prepared by Clinical Oncology Week ...
2009 SEP 21 ... transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma,' are discussed in a new report. According to recent research from Wurzburg, Germany, ...
2009 JUL 20 ... their study in the Journal of Clinical Endocrinology & Metabolism (Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists. Journal of Clinical ...
2009 NOV 9 ... carcinomas are rare. This case series is reported to give an overview of how adrenocortical carcinoma is currently managed in the UK." "A retrospective review was made of case ...
2009 SEP 14 ... PCR analysis revealed down-regulation of BMP2 and BMP5 in tissue samples from adrenocortical carcinoma and adrenocortical tumor cell lines compared with normal adrenal glands," researchers ...
2009 OCT 5 ... Healthcare announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands. TCRS is a ...
2009 SEP 14 ... drive. Less well understood is the genetics of adrenal cortex tumors, in particular adrenocortical carcinoma, a rare and particularly aggressive disease," wrote G. Opocher and colleagues, ...
2009 AUG 3 ... nestin expression has recently been detected in several tumors." "Since adrenocortical carcinoma, a tumor entity still very difficult to classify, may gain the ability to aberrantly ...
2009 SEP 14 ... more traditional approaches remain necessary for management of known or suspected adrenocortical carcinoma. Except in the case of pheochromocytoma, large adrenal tumors >6 cm should not be ...
2009 SEP 21 ... research, 'Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy,' is the subject of a report. ...
2009 NOV 1 ... "Different pathophysiological situations such as congenital adrenal hyperplasia, adrenocortical carcinoma, metyrapone treatment, etc. elicit specificity problems with serum cortisol assay. We ...
